Medical emergency?Emergency? Call 911. Nearest emergency roomsNearest ERs

Drug company (FDA labeler)

Sun Pharmaceutical Industries, Inc.

NDC labeler codes: 10631, 45567, 47335, 49708, 51672, 53489, 57664, 62756, 63304, 70095

What is a labeler?

The company whose name is on the package and in the FDA’s National Drug Code (NDC) Directory. It may make the medicine itself or sell medicine made by another company. The first part of every NDC code identifies the labeler.

Official FDA data only

Products, approvals and recalls come from the FDA (NDC Directory, Drugs@FDA, enforcement reports). Recalls are linked to this company by the NDC labeler code on the recalled product.

Questions about your medicine: ask your doctor or pharmacist. In an emergency, call 911.

At a glance

653Products (NDC)

Prescription medicines

Show the other 190 medicines

FDA applications for these products

  • NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
  • ANDA: Abbreviated New Drug Application: how a generic version is approved.
  • BLA: Biologics License Application: how a biologic medicine (made from living cells) is approved.
ApprovedApplicationMedicineSponsor
August 31, 2026ANDA210232 Pomalidomide
POMALIDOMIDE
Spil
July 28, 2026ANDA214319 Sugammadex
SUGAMMADEX SODIUM
Sun Pharm Inds Inc
June 15, 2026ANDA219052 Perampanel
PERAMPANEL
Taro
June 3, 2026ANDA204196 Dextromethorphan hydrobromide and quinidine sulfate
DEXTROMETHORPHAN HYDROBROMIDE AND QUINIDINE SULFATE
Sun Pharm
June 3, 2026ANDA218407 Tofacitinib
TOFACITINIB CITRATE
Sun Pharm Inds Inc
April 28, 2026ANDA213919 Doxepin hydrochloride
DOXEPIN HYDROCHLORIDE
Sun Pharma Canada
April 6, 2026ANDA211491 Dapagliflozin and metformin hydrochloride
DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE
Sun Pharm
March 13, 2026ANDA216298 Phytonadione
PHYTONADIONE
Orbicular
January 27, 2026ANDA219930 Deflazacort
DEFLAZACORT
Sun Pharm Inds Inc
November 25, 2025ANDA209538 Perampanel
PERAMPANEL
Taro
October 7, 2025ANDA219677 Lamotrigine
LAMOTRIGINE
Taro
August 26, 2025ANDA211123 Macitentan
MACITENTAN
Sun Pharm
August 6, 2025ANDA219058 Doxepin hydrochloride
DOXEPIN HYDROCHLORIDE
Taro
March 18, 2025ANDA217741 Deflazacort
DEFLAZACORT
Sun Pharm
March 3, 2025ANDA208557 Rivaroxaban
RIVAROXABAN
Taro
December 13, 2024ANDA218858 Lactulose
LACTULOSE
Taro
December 13, 2024BLA761297 Cosibelimab
UNLOXCYT
Checkpoint Therapeutics Inc
September 27, 2024NDA213224 Octreotide acetate
BYNFEZIA PEN
Sun Pharm
September 25, 2024ANDA203857 Glatiramer acetate
GLATIRAMER ACETATE
Synthon Bv
September 25, 2024ANDA206873 Glatiramer acetate
GLATIRAMER ACETATE
Synthon Bv
July 25, 2024NDA217900 Deuruxolitinib phosphate
LEQSELVI
Sun Pharm Inds Inc
June 14, 2024ANDA218011 Diclofenac
DICLOFENAC POTASSIUM
Taro
June 12, 2024ANDA205470 Acyclovir
ACYCLOVIR
Sun Pharma Canada
March 19, 2024ANDA206431 Sodium sulfate, potassium sulfate, magnesium sulfate
SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE
Taro
January 18, 2024ANDA217617 Bisoprolol fumarate
BISOPROLOL FUMARATE
Harman Finochem
Show the other 100 applications
ApprovedApplicationMedicineSponsor
December 7, 2023ANDA218182 Lidocaine
LIDOCAINE HYDROCHLORIDE
Sun Pharma Canada
October 19, 2023ANDA215837 Pazopanib
PAZOPANIB HYDROCHLORIDE
Sun Pharm
September 27, 2023ANDA215997 Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate
DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE
Sun Pharm Inds Inc
August 25, 2023ANDA214134 Lisdexamfetamine dimesylate
LISDEXAMFETAMINE DIMESYLATE
Sun Pharm Inds Inc
August 25, 2023ANDA214484 Lisdexamfetamine dimesylate
LISDEXAMFETAMINE DIMESYLATE
Sun Pharm Inds Inc
August 25, 2023ANDA217229 Methylphenidate
METHYLPHENIDATE HYDROCHLORIDE
Sun Pharm Inds Inc
July 24, 2023ANDA213458 Bumetanide
BUMETANIDE
Taro
June 28, 2023ANDA217594 Sodium bicarbonate
SODIUM BICARBONATE
Steriscience
March 20, 2023ANDA216904 Desmopressin acetate
DESMOPRESSIN ACETATE
Gland
February 8, 2023ANDA211846 Lenalidomide
LENALIDOMIDE
Sun Pharm
January 5, 2023ANDA215713 Tretinoin
TRETINOIN
Sun Pharma Canada
November 17, 2022NDA215910 Phenobarbital sodium
SEZABY
Sun Pharm Inds Inc
November 16, 2022ANDA216922 Desmopressin acetate
DESMOPRESSIN ACETATE
Gland
September 29, 2022ANDA208098 Diclofenac
DICLOFENAC SODIUM
Sun Pharma Canada
August 30, 2022ANDA210470 Ciprofloxacin and dexamethasone
CIPROFLOXACIN AND DEXAMETHASONE
Sun Pharm
July 5, 2022ANDA212467 Glycopyrrolate
GLYCOPYRROLATE
Cohance Lifesciences
May 26, 2022ANDA215385 Arformoterol tartrate
ARFORMOTEROL TARTRATE
Sun Pharm
May 18, 2022ANDA204400 Pantoprazole sodium
PANTOPRAZOLE SODIUM
Gland
May 11, 2022ANDA214585 Mesalamine
MESALAMINE
Sun Pharm
April 14, 2022ANDA215674 Fluphenazine hydrochloride
FLUPHENAZINE HYDROCHLORIDE
Taro
March 17, 2022ANDA205031 Lacosamide
LACOSAMIDE
Sun Pharm
February 28, 2022NDA216018 Ranolazine
ASPRUZYO SPRINKLE
Spil
December 14, 2021ANDA212514 Amphotericin b
AMPHOTERICIN B
Spil
October 4, 2021ANDA213584 Oxymetazoline hydrochloride
OXYMETAZOLINE HYDROCHLORIDE
Sun Pharma Canada
October 1, 2021ANDA214089 Mexiletine hydrochloride
MEXILETINE HYDROCHLORIDE
Pharmazone
August 16, 2021ANDA213914 Sunitinib malate
SUNITINIB MALATE
Sun Pharm
June 28, 2021ANDA214526 Clindamycin
CLINDAMYCIN PHOSPHATE
Sun Pharma Canada
June 17, 2021ANDA213906 Levorphanol tartrate
LEVORPHANOL TARTRATE
Sun Pharm Inds Inc
April 14, 2021ANDA211922 Budesonide
BUDESONIDE
Sun Pharm
March 25, 2021ANDA214867 Clobetasol propionate
CLOBETASOL PROPIONATE
Sun Pharma Canada
February 26, 2021ANDA212450 Loteprednol etabonate
LOTEPREDNOL ETABONATE
Sun Pharm
February 18, 2021ANDA214384 Droxidopa
DROXIDOPA
Sun Pharm
January 26, 2021ANDA205971 Imiquimod
IMIQUIMOD
Taro
January 15, 2021ANDA210473 Epoprostenol
EPOPROSTENOL SODIUM
Sun Pharm
November 10, 2020ANDA214052 Clindamycin
CLINDAMYCIN PHOSPHATE
Sun Pharma Canada
September 2, 2020ANDA213269 Calcipotriene and betamethasone dipropionate (betamethasone dipropionate / calcipotriene)
CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE
Sun Pharma Canada
August 26, 2020NDA213433 Clascoterone
WINLEVI
Sun Pharm
August 3, 2020ANDA212435 Metronidazole
METRONIDAZOLE IN PLASTIC CONTAINER
Gland
July 10, 2020ANDA213917 Magnesium sulfate heptahydrate
MAGNESIUM SULFATE IN PLASTIC CONTAINER
Gland
July 1, 2020ANDA213046 Butalbital, acetaminophen and caffeine
BUTALBITAL, ACETAMINOPHEN AND CAFFEINE
Taro
June 30, 2020ANDA213725 Pantoprazole sodium
PANTOPRAZOLE SODIUM
Sun Pharm
June 17, 2020ANDA211722 Betamethasone dipropionate
BETAMETHASONE DIPROPIONATE
Sun Pharma Canada
April 27, 2020ANDA207116 Mupirocin
MUPIROCIN
Sun Pharma Canada
April 21, 2020ANDA206370 Clocortolone pivalate
CLOCORTOLONE PIVALATE
Taro
March 11, 2020ANDA210004 Clindamycin
CLINDAMYCIN PHOSPHATE
Taro
December 26, 2019ANDA207136 Tobramycin
TOBRAMYCIN
Sun Pharm
December 4, 2019ANDA208014 Fingolimod
FINGOLIMOD HYDROCHLORIDE
Sun Pharm
November 29, 2019ANDA091157 Pregabalin
PREGABALIN
Sun Pharm
November 20, 2019ANDA204024 Fosamprenavir calcium
FOSAMPRENAVIR CALCIUM
Sun Pharm
November 20, 2019ANDA209782 Deferasirox
DEFERASIROX
Sun Pharm
November 5, 2019NDA211913 Isotretinoin
ABSORICA LD
Sun Pharm
August 23, 2019ANDA210549 Azelaic acid
AZELAIC ACID
Sun Pharma Canada
August 19, 2019ANDA077674 Pantoprazole sodium
PANTOPRAZOLE SODIUM
Sun Pharm
August 19, 2019ANDA206575 Clindamycin phosphate and benzoyl peroxide
CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE
Sun Pharma Canada
July 19, 2019NDA212516 Duloxetine
DRIZALMA SPRINKLE
Sun Pharm
July 12, 2019ANDA208994 Technescan tc 99M mertiatide
TECHNETIUM TC99M MERTIATIDE KIT
Sun Pharm Inds Inc
July 1, 2019ANDA205467 Febuxostat
FEBUXOSTAT
Sun Pharm
June 26, 2019ANDA210191 Dapsone
DAPSONE
Sun Pharma Canada
June 21, 2019ANDA204668 Capecitabine
CAPECITABINE
Sun Pharm
May 21, 2019ANDA208292 Dalfampridine
DALFAMPRIDINE
Sun Pharm
May 1, 2019ANDA210760 Medroxyprogesterone acetate
MEDROXYPROGESTERONE ACETATE
Sun Pharm
April 26, 2019ANDA209324 Bosentan
BOSENTAN
Sun Pharm
April 24, 2019ANDA210761 Medroxyprogesterone acetate
MEDROXYPROGESTERONE ACETATE
Sun Pharm
April 15, 2019ANDA210978 Clobazam
CLOBAZAM
Taro
April 10, 2019ANDA208201 Naftifine hydrochloride
NAFTIFINE HYDROCHLORIDE
Sun Pharma Canada
March 28, 2019ANDA210784 Ambrisentan
AMBRISENTAN
Sun Pharm
March 26, 2019ANDA208934 Tadalafil
TADALAFIL
Sun Pharm
March 1, 2019ANDA209430 Dapsone
DAPSONE
Taro
February 21, 2019ANDA204556 Calcitriol
CALCITRIOL
Sun Pharm
February 8, 2019ANDA208800 Deferiprone
DEFERIPRONE
Taro
January 25, 2019ANDA211644 Tretinoin
TRETINOIN
Sun Pharma Canada
January 25, 2019ANDA211858 Mesalamine
MESALAMINE
Sun Pharm
January 22, 2019ANDA211645 Tretinoin
TRETINOIN
Sun Pharma Canada
January 4, 2019ANDA208066 Lurasidone hydrochloride
LURASIDONE HYDROCHLORIDE
Sun Pharm
November 21, 2018ANDA211477 Fluoxetine
FLUOXETINE HYDROCHLORIDE
Somerset Theraps LLC
November 5, 2018ANDA207820 Levalbuterol
LEVALBUTEROL HYDROCHLORIDE
Sun Pharm
October 17, 2018ANDA209148 Adapalene and benzoyl peroxide
ADAPALENE AND BENZOYL PEROXIDE
Sun Pharma Canada
October 11, 2018ANDA207008 Cinacalcet
CINACALCET HYDROCHLORIDE
Sun Pharm
October 9, 2018ANDA210466 Dofetilide
DOFETILIDE
Sun Pharm
October 4, 2018ANDA208779 Clobetasol propionate
CLOBETASOL PROPIONATE
Taro
September 12, 2018NDA206185 Latanoprost
XELPROS
Sun Pharm
August 14, 2018NDA210913 Cyclosporine
CEQUA
Sun Pharm
July 20, 2018ANDA202803 Sumatriptan and naproxen sodium
SUMATRIPTAN AND NAPROXEN SODIUM
Sun Pharm
June 5, 2018ANDA208683 Clindamycin phosphate and benzoyl peroxide
CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE
Sun Pharma Canada
May 22, 2018NDA210308 Abiraterone acetate
YONSA
Sun Pharm
May 8, 2018ANDA201691 Hydroxychloroquine sulfate
HYDROXYCHLOROQUINE SULFATE
Alkaloida Zrt
April 30, 2018ANDA209735 Esomeprazole
ESOMEPRAZOLE MAGNESIUM
Sun Pharm
April 6, 2018ANDA205618 Paliperidone
PALIPERIDONE
Sun Pharm
March 26, 2018ANDA208842 Clobetasol propionate
CLOBETASOL PROPIONATE
Sun Pharma Canada
March 20, 2018BLA761067 Tildrakizumab-asmn
ILUMYA
Sun Pharma Global
January 26, 2018NDA210428 Metoprolol
KAPSPARGO SPRINKLE
Spil
January 24, 2018ANDA206959 Adapalene and benzoyl peroxide
ADAPALENE AND BENZOYL PEROXIDE
Sun Pharma Canada
December 15, 2017ANDA206218 Clindamycin phosphate and benzoyl peroxide
CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE
Sun Pharma Canada
October 25, 2017ANDA090132 Carvedilol
CARVEDILOL PHOSPHATE
Sun Pharm Industries
October 16, 2017ANDA209506 Dapsone
DAPSONE
Sun Pharma Canada
August 7, 2017ANDA207875 Ipratropium bromide and albuterol sulfate
ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE
Sun Pharm
July 21, 2017ANDA207857 Albuterol sulfate
ALBUTEROL SULFATE
Sun Pharm
June 23, 2017ANDA209204 Ibuprofen
IBUPROFEN
Sun Pharma Canada
June 16, 2017ANDA206314 Felbamate
FELBAMATE
Taro
June 8, 2017ANDA203023 Diltiazem
DILTIAZEM HYDROCHLORIDE
Sun Pharm

Showing the 125 newest of 344 applications. Full lists: Drugs@FDA →

The sponsor is the company that holds the FDA application; it can differ from the labeler.

Recall timeline

2026

  1. May 29, 2026 · Class II · Ongoing · D-0607-2026 · Budesonide

    Presence of Foreign Substance:This recall has been initiated in response to a product quality complaint reported for black/brown specs and particles within the ampoule solution

    Budesonide Inhalation Suspension, 1mg/2mL, 30 x 2 mL Sterile Single-Dose Ampules (5 Single-Dose Ampules per pouch, 6 pouches per carton, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactur

2025

  1. September 3, 2025 · Class II · Ongoing · D-0658-2025 · Technescan tc 99M mertiatide

    Failed Dissolution Specifications-Out of Specification (OOS) observation for sulphate in Sodium Tartrate Dihydrate used for the production of Mertiatide.

    Kit for the Preparation of Technetium Tc 99m Mertiatide, Rx Only, Manufactured by: Sun Pharmaceutical Industries, Inc. Billerica, MA 01821, NDC 45567-0655-1

  2. August 5, 2025 · Class II · Ongoing · D-0574-2025 · Spironolactone

    Presence of foreign substance: identified as aluminum.

    Spironolactone Tablets, USP, 25 mg, 100-count bottle, Rx only, Mfg. by: Frontida BioPharm, Inc., 1100 Orthodox St, Philadelphia, PA 19124, Dist. by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, NDC 53489-143-

  3. March 4, 2025 · Class III · Ongoing · D-0311-2025 · Gabapentin

    Cross Contamination

    Gabapentin Capsules, USP 300 mg, Rx Only, Packaged in a) 500-count bottles, NDC 62756-138-05; b) 1000-count bottles, NDC 62756-138-04, Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, Manufactured

  4. March 4, 2025 · Class III · Ongoing · D-0312-2025 · Gabapentin

    Cross Contamination

    Gabapentin Capsules, USP 400 mg, Rx Only, Packaged in a) 500-count bottles, NDC 62756-139-05; b) 1000-count bottles, NDC 62756-139-04; Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, Manufactured

  5. February 6, 2025 · Class II · Ongoing · D-0249-2025 · Morphine sulfate

    Failed Dissolution Specifications

    Morphine Sulfate Extended-Release Tablets, 100 mg, 100-count bottles, Rx Only, Manufactured by: Ohm Laboratories Inc., New Brunswick, NJ 08901. Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512. NDC

2024

  1. April 22, 2024 · Class III · Ongoing · D-0502-2024 · Latanoprost

    Failed Release Testing: Out of specification for particulate matter test.

    Xelpros (latanoprost ophthalmic emulsion) 0.005%, 125mcg/2.5mL, 2.5 mL bottle, Rx only, Manufactured by: Sun Pharmaceutical Ind. Ltd., India., NDC 47335-317-90

  2. April 19, 2024 · Class II · Ongoing · D-0493-2024 · Amphotericin b

    Out of specification for assay

    Amphotericin B Liposome for Injection, 50mg vials, Rx only, Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Medicare Limited, Baska Ujeti Road, Ujeti Halol-3893

  3. February 5, 2024 · Class II · Ongoing · D-0350-2024 · Mesalamine

    Failed Dissolution Specifications: Out of specification for dissolution.

    Mesalamine Extended-Release Capsules, USP 500mg, Rx Only, 120 Capsules per bottle, Manufactured by: Sun Pharmaceutical Industries Limited, Mohali, INDIA, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ

  4. January 18, 2024 · Class II · Completed · D-0271-2024 · Zolpidem tartrate

    CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.

    Zolpidem Tartrate Extended-Release Tablets, USP 6.25 mg, Rx Only, 100 Tablets per bottle, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Limited, S

Show the 50 older recalls

2024

  1. January 18, 2024 · Class II · Completed · D-0270-2024 · Niacin

    CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.

    Niacin Extended-Release Tablets, USP 500mg, Rx Only, 90 Tablets per bottle, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Limited, Survey No. 259/

  2. January 18, 2024 · Class II · Completed · D-0265-2024 · Febuxostat

    CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.

    Febuxostat Tablets 80 mg, Rx Only, 30 Tablets per bottle, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Ltd., Survey No. 259/15, Dadra-396 191, (U

  3. January 18, 2024 · Class II · Completed · D-0264-2024 · Febuxostat

    CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.

    Febuxostat Tablets 40mg, Rx Only, 30 Tablets per bottle, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Ltd., Survey No. 259/15, Dadra-396 191 (U.T

  4. January 18, 2024 · Class II · Completed · D-0263-2024 · Cinacalcet

    CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.

    Cinacalcet Tablets 60mg, Rx Only, 30 Tablets per bottle, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Limited Survey No. 259/15, Dadra-396 191 (U

  5. January 18, 2024 · Class II · Completed · D-0268-2024 · Mesalamine

    CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.

    Mesalamine Delayed-Release Tablets, USP 1.2 g per tablet, Rx Only, 120 Tablets per bottle, Once Daily, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industri

  6. January 18, 2024 · Class II · Completed · D-0269-2024 · Niacin

    CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.

    Niacin Extended-Release Tablets, USP 1000mg, Rx Only, 90 Tablets per bottle, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Limited, Survey No. 259

  7. January 18, 2024 · Class II · Completed · D-0272-2024 · Zolpidem tartrate

    CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.

    Zolpidem Tartrate Extended-Release Tablets, USP 12.5mg, Rx Only, 100 Tablets per bottle, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Limited, Su

  8. January 18, 2024 · Class II · Completed · D-0266-2024 · Lurasidone hydrochloride

    CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.

    Lurasidone Hydrochloride Tablets 60mg, Rx Only, 30 Tablets per bottle, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Ltd., Survey No. 259/15, Dadr

  9. January 18, 2024 · Class II · Completed · D-0267-2024 · Lurasidone hydrochloride

    CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.

    Lurasidone Hydrochloride Tablets 120mg, Rx Only, 30 Tablets per bottle, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Ltd., Survey No. 259/15, Dad

2023

  1. December 4, 2023 · Class II · Terminated · D-0150-2024 · Liothyronine sodium

    Failed Impurities/Degradation Specifications

    Liothyronine Sodium Tablets, USP 5 mcg, 100-count bottle, Rx Only, Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512 Manufactured by: Sun Pharmaceutical Industries Ltd. Survey No. 259/15, Dadra-396 1

  2. October 20, 2023 · Class II · Terminated · D-0083-2024 · Liothyronine sodium

    Failed Impurities/Degradation Specifications.

    Liothyronine Sodium Tablets, USP, 5 mcg, 100-count bottles, Rx only, Distributed by: Sun Pharmaceutical Industries, Inc.Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Ltd. Survey No. 259/15, Dadra-396

  3. October 20, 2023 · Class II · Terminated · D-0084-2024 · Liothyronine sodium

    Failed Impurities/Degradation Specifications.

    Liothyronine Sodium Tablets, USP, 25 mcg, 100-count bottles, Rx only, Distributed by: Sun Pharmaceutical Industries, Inc.Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Ltd. Survey No. 259/15, Dadra-39

  4. September 7, 2023 · Class III · Terminated · D-1172-2023 · Cyclosporine

    Subpotent: Out of Specification result observed for low assay

    Cequa (cyclosporine ophthalmic solution) 0.09%, 60 Single-Use Vials (6 pouches x 10 single-use vials (0.25 mL each)), Rx only, Manufactured for Sun Pharma Global FZE by: Laboratoire Unither, Coutances, France NDC 47335-5

  5. July 18, 2023 · Class III · Terminated · D-1082-2023 · Dofetilide

    Out of Specification result observed in content uniformity testing

    Dofetilide Capsules 500 mcg (0.5mg), 60-count bottle, Rx Only, Manufactured by Sun Pharmaceutical Industries Limited, Survey No. 259/15, Dadra-396 191, (U.T of D & NH), India, Distributed by: Sun Pharmaceutical Industrie

  6. July 10, 2023 · Class II · Terminated · D-0914-2023 · Tiagabine hydrochloride

    Failed Impurities: Out of Specification (OOS) result observed during Related Substances testing

    Tiagabine Hydrochloride Tablets, 2 mg, 30-count bottle, Distributed by Sun Pharmaceutical Industries. Inc. Cranbury NJ 08512, Manufactured by: Sun Pharmaceutical Industries Limited Halol-Baroda Highway, Halol-389 350, Gu

  7. July 5, 2023 · Class III · Terminated · D-0924-2023 · Loteprednol etabonate

    Superpotent Drug: Out of Specification (OOS) results observed for unit dose content.

    Loteprednol Etabonate Ophthalmic Suspension, 5 mg/mL (0.5%), packaged as one bottle in a carton in a) 10 mL bottle (NDC# 62756-232-55) and b) 15 mL bottle (NDC # 62756-232-56), Rx only, Distributed by: Sun Pharmaceutical

  8. May 3, 2023 · Class II · Terminated · D-0869-2023 · Buprenorphine

    CGMP Deviations

    Buprenorphine Sublingual Tablets, 8 mg, 30 count-bottles, Rx only, Manufactured by: Sun Pharma, NDC 62756-460-83.

  9. January 13, 2023 · Class II · Terminated · D-0262-2023 · Diltiazem

    Failed Impurity (Deacetyl Diltiazem Hydrochloride) specification during stability testing and failed dissolution testing at FDA laboratory.

    Diltiazem Hydrochloride Extended-Release Capsules, USP, 360 mg; Rx only; 90-count bottles, Manufactured by: Sun Pharmaceutical Industries Ltd. Halol-Baroda Highway, Halol-389350, Gujarat, India; Distributed by: Sun Pharm

2022

  1. December 1, 2022 · Class II · Terminated · D-0085-2023 · Oxcarbazepine

    Presence of foreign substance

    Oxcarbazepine Tablets 600mg, packaged in a) 100- count bottles (NDC 62756-185-88), b) 500-count bottles (NDC 62756-185-13), c)1000-count bottles (NDC 62756-185-18), Rx Only, Distributed by: Sun Pharmaceutical Industries,

  2. October 18, 2022 · Class II · Terminated · D-0024-2023 · Buprenorphine and naloxone

    Presence of Foreign Substance

    Buprenorphine and Naloxone Sublingual Tablets 8 mg/2 mg, 30-count bottles, Rx only, Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512 Manufactured by: Sun Pharmaceutical Industries Ltd. Survey No. 25

  3. July 25, 2022 · Class II · Terminated · D-0068-2023 · Pantoprazole sodium

    Discoloration

    Pantoprazole Sodium for Delayed-Release Oral Suspension*40 mg* suspension in apple juice or applesauce only Each packet contains 40 mg pantoprazole equivalent to 45.1 mg of pantoprazole sodium USP (sesquihydrate), Rx Onl

  4. June 27, 2022 · Class II · Terminated · D-1291-2022 · Divalproex sodium

    Failed Dissolution Specifications: Failure occurred during routine stability testing of dissolution test.

    Divalproex Sodium Delayed-Release Tablets, USP 500mg, Rx Only, 100 Tablets, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries, Ltd., Halol-Baroda High

  5. June 21, 2022 · Class III · Terminated · D-0005-2023 · Esomeprazole

    Superpotent Drug: Out of specification for assay at the 12-month timepoint.

    Esomeprazole Magnesium Delayed-Release Capsules, USP, 40mg, Rx Only, 90 Capsules per bottle, Manufactured by: Ohm Laboratories Inc. New Brunswick, NJ 08901, Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, N

  6. June 21, 2022 · Class III · Terminated · D-0004-2023 · Esomeprazole

    Superpotent Drug: Out of specification for assay at the 12-month timepoint.

    Esomeprazole Magnesium Delayed-Release Capsules, USP 20mg, Rx Only, 90 Capsules per bottle, Manufactured by: Ohm Laboratories Inc. New Brunswick, NJ 08901, Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ

  7. June 21, 2022 · Class II · Terminated · D-1190-2022 · Testosterone cypionate

    cGMP - Water leakage

    Testosterone Cypionate Injection, USP, 200mg/mL, CIII, Rx only, 1mL Single-dose vial, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceuticals Industries Ltd., Halol-

  8. June 10, 2022 · Class II · Terminated · D-1154-2022 · Testosterone cypionate

    Lack of Assurance of Sterility: Manufacturing deviation which was reported due to a microbial excursion

    Testosterone Cypionate Injection, USP, 200 mg/mL, 1 mL Single-dose vial per carton, Rx only, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512; Manufactured by: Sun Pharmaceutical Industries Ltd., H

  9. June 3, 2022 · Class II · Terminated · D-1153-2022 · Testosterone cypionate

    CGMP Deviations: lots made with same active pharmaceutical ingredient (API) as lots that were rejected due to manufacturing issues that could cause the product to be out of specification for impurities.

    Testosterone Cypionate Injection, USP, 200 mg/mL, 1 mL Single-dose vial per carton, Rx only, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512; Manufactured by: Sun Pharmaceutical Industries Ltd., H

  10. June 3, 2022 · Class II · Terminated · D-1176-2022 · Testosterone cypionate

    CGMP Deviations: Manufacturing deviations were reported due to an abnormal appearance on parts of machinery.

    Testosterone Cypionate Injection, USP, 200mg/ml, Rx Only, One Single-dose vial, Distributed by: Sun Pharmaceutical Industries Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceuticals Industries Ltd., Halol-Baroda H

  11. May 6, 2022 · Class II · Terminated · D-1145-2022 · Medroxyprogesterone acetate

    Lack of assurance of sterility

    medroxyPROGESTERone Acetate Injectable Suspension, USP, 1 mL Prefilled Syringe, 150 mg/mL, Rx only, Manufactured by Sun Pharmaceutical Industries Ltd., Halol-Baroda Highway, Halol-389 350, Gujarat, India, Distributed by:

  12. April 13, 2022 · Class II · Terminated · D-1032-2022 · Doxycycline

    cGMP deviations: Temperature abuse

    Doxycycline Capsules, USP, 100 mg, 50-count bottle, Rx only, Distributed by: Sun Pharmaceuticals, NDC 63304-616-50

  13. April 13, 2022 · Class II · Terminated · D-1111-2022 · Sumatriptan

    cGMP deviations: Temperature abuse

    Sumatriptan Succinate Tablets, 100 mg, 9 (1 x 9) Unit-of- use tablets box, Rx only, MFG: Sun Pharmaceuticals, NDC 62756-522-69

  14. April 1, 2022 · Class III · Terminated · D-0770-2022 · Cyclosporine

    Subpotent Drug and Presence of Particulate Matter: low out-of-specification results obtained for assay and the presence of particulate matter.

    Cequa (cyclosporine ophthalmic solution) 0.09%, packaged in 6 pouches x 10 single-use vials (0.25 mL each) per box, Manufactured for Sun Pharma Global FZE by: Laboratoire Unither, ZI de la Guerie, F-50211 Coutances Cedex

2021

  1. October 22, 2021 · Class II · Terminated · D-0361-2022 · Pregabalin

    Failed Tablet/Capsule Specifications: Out of Specification results for particle Size Distribution and Bulk Density of the Active Pharmaceutical Ingredient.

    Pregabalin Capsules, 50 mg, 100 count bottle, Rx only, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Ltd., Survey No. 259/15 Dadra-396 191, (U.T.

  2. May 7, 2021 · Class III · Terminated · D-0391-2021 · Cyclosporine

    Subpotent and Presence of Particulates .

    Cequa (cyclosporine ophthalmic solution) 0.09%, 60 Single-Use Vials (6 pouches x 10 single-use vials (0.25 mL each)), Rx only, Manufactured for Sun Pharma Global FZE by: Laboratoire Unither, Coutances, France Distributed

  3. May 4, 2021 · Class II · Terminated · D-0372-2021 · Metformin hydrochloride

    Presence of foreign substance: identified as activated carbon.

    Metformin HCl Extended-Release Tablets, USP, 500 mg, packaged in 500-count bottles, Rx only, Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Ltd., Ha

  4. March 25, 2021 · Class III · Terminated · D-0325-2021 · Metformin hydrochloride

    Failed Moisture Limits: Out of specification for water content

    Metformin HCl Extended-Release Tablets, USP, 500 mg, Rx Only, 500-count bottle, Rx only, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512; Manufactured by: Sun Pharmaceutical Industries Ltd., Halol

  5. March 15, 2021 · Class II · Terminated · D-0568-2021 · Clindamycin

    CGMP Deviations: Intermittent exposure to temperature excursion during storage.

    CLINDAMYCIN HYDROCHLORIDE CAPSULES, USP,150MG 100-count bottles, Rx Only, Manufactured by: Ohm Laboratories Inc. New Brunswick, NJ 08901, Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, NDC 63304-

  6. February 22, 2021 · Class III · Terminated · D-0289-2021 · Cyclosporine

    Subpotent

    Cequa (cyclosporine ophthalmic solution) 0.09%, 60 Single-Use Vials (6 pouches x 10 single-use vials (0.25 mL each)), Rx only, Manufactured for Sun Pharma Global FZE by: Laboratoire Unither, Coutances, France NDC 47335-5

  7. February 5, 2021 · Class III · Terminated · D-0251-2021 · Pantoprazole sodium

    Failed Impurity/Degradation Specifications

    Pantoprazole Sodium for Injection 40mg/vial For I.V. infusion only Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512 Manufactured by: Sun Pharmaceutical Industries Ltd. Halol-Baroda Highway, Halol-38

  8. January 11, 2021 · Class III · Terminated · D-0242-2021 · Testosterone cypionate

    Incorrect Labeling: Incorrect lot number on secondary packaging

    Testosterone Cypionate Injection, USP CIII 200mg/ml FOR INTRAMUSCULAR USE ONLY 1mL Single-dose vial Distributed by: Sun Pharma Ind. Inc, NJ 08512 Manufactured by: Sun Pharma Ind. Ltd., India NDC 62756-015-40

2020

  1. March 13, 2020 · Class II · Terminated · D-1032-2020 · Doxycycline

    CGMP Deviations: Doxycycline capsules were not manufactured under Current Good Manufacturing Practice conditions.

    Doxycycline Capsules, USP, 75 mg, 100-count bottle, Rx only, Manufactured by: Ohm Laboratories Inc., New Brunswick, NJ 08901; Distributed by Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512; NDC 63304-615-01.

  2. March 13, 2020 · Class II · Terminated · D-1033-2020 · Doxycycline

    CGMP Deviations: Doxycycline capsules were not manufactured under Current Good Manufacturing Practice conditions.

    Doxycycline Capsules, USP, 100 mg, 50-count bottle, Rx only, Manufactured by: Ohm Laboratories Inc., New Brunswick, NJ 08901; Distributed by Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512; NDC 63304-616-50.

  3. January 14, 2020 · Class II · Terminated · D-0787-2020 · Testosterone cypionate

    cGMP Deviations; released lots were manufactured under similar manufacturing conditions to a previously rejected OOS Lot.

    Testosterone Cypionate for Injection, USP, 1,000 mg/10 mL (100 mg/mL), 10 mL Multiple Dose Vial (NDC 62756-017-40), Rx only, Distributed by: Sun Pharmaceuticals, Inc., Cranbury, NJ, Manufactured by: Sun Pharmaceuticals,

  4. January 14, 2020 · Class II · Terminated · D-0788-2020 · Testosterone cypionate

    cGMP Deviations; released lots were manufactured under similar manufacturing conditions to a previously rejected OOS Lot.

    Testosterone Cypionate for Injection, 2,000 mg/10 mL (200 mg/mL), a) 1 mL Single Use vial (NDC 62756-015-40) and b) 10 mL Multiple Dose Vial (NDC 62756-016-40), Rx only, Distributed by: Sun Pharmaceuticals, Inc., Cranbur

2019

  1. December 26, 2019 · Class II · Terminated · D-0659-2020 · Sumatriptan

    Failed Impurities/Degradation Specifications; out-of-specification results obtained for related substance.

    Sumatriptan Succinate Tablets, 50 mg, packaged in a) 9 (1x9) Unit-of use blister card (NDC 62756-521-69) and b) 100 count bottles, (NDC 62756-521-88), Rx only, Sun Pharma, Cranbury, NJ

  2. January 24, 2019 · Class II · Terminated · D-0422-2019 · Bromfenac

    Bromfenac Ophthalmic Solution, 0.075% (Sterile 5 mL) may have a lack of sterility assurance.

    BromSite (bromfenac ophthalmic solution) 0.075%, 5 mL bottles, Rx Only, Distributed by : Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, NDC 49708-754-41

  3. January 3, 2019 · Class I · Terminated · D-0373-2019 · Vecuronium bromide

    Presence of Particulate Matter: Foreign matter identified as glass detected in Vecuronium Bromide for Injection.

    Vecuronium Bromide for Injection 20 mg* *1mg/mL when reconstituted to 20 mL Lyophilized, 10 x 20 mg vials, Rx Only, Manufactured by: Sun Pharmaceutical Industries Ltd. Halol-Baroda Highway Halol-389 350, Gujarat, India.

  4. January 3, 2019 · Class I · Terminated · D-0372-2019 · Vecuronium bromide

    Presence of Particulate Matter: Foreign matter identified as glass detected in Vecuronium Bromide for Injection.

    Vecuronium Bromide for Injection 10 mg*, *1mg/mL when reconstituted to 10 mL Lyophilized, 10 x 10 mg vials, Rx only, Manufactured by: Sun Pharmaceutical Industries Ltd. Halol-Baroda Highway Halol-389 350, Gujarat, India.

2018

  1. December 7, 2018 · Class III · Terminated · D-1207-2019 · Isotretinoin

    Subpotent Drug: Isotretinoin content results were lower than the specification limit obtained during routing product monitoring.

    Absorica (Isotretinoin) Capsules 30 mg USP, 30 capsules (3x10 Prescription Packs) Rx only, Manufactured by: Galephar Pharmaceutical Research Inc. Humacao, PR 00792, Distributed by: Sun Pharmaceutical Industries Inc. Cran

  2. July 12, 2018 · Class II · Terminated · D-0977-2018 · Testosterone cypionate

    Presence of Particulate Matter: organic and inorganic compounds detected in vials of product.

    Testosterone Cypionate Injection, USP, 200 mg/mL, Rx only, 10 mL vials, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries, Ltd., Halol-Baroda Highway,

Showing the newest 60 of 72.

What do the recall classes mean?

Class I: The most serious type: there is a reasonable chance that using the product will cause serious health problems or death.
Class II: Using the product may cause temporary or medically reversible health problems, or the chance of serious problems is remote.
Class III: Using the product is not likely to cause health problems (for example a labeling or packaging issue).

Sources

  1. NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  2. Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  3. Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026

FDA Enforcement Report search → · Report an error →